Drug Type CAR-T |
Synonyms Universal LCAR-BCX cell therapy (Nanjing Legend Biotech), LCAR-BCX |
Target |
Action inhibitors |
Mechanism BCMA inhibitors(B-cell maturation protein inhibitors), Gene transference(Gene transference), T lymphocyte replacements |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |





